cancer discovery aacr journals
efficacy of bsi 201 a parp inhibitor in combination with gemcitabine carboplatin in triple negative metastatic breast cancer results of a phase ii study ppt download
nucleotide excision repair
molecular biology of the cell
translational cancer research ame publishing company
https europepmc org article pmc 6591728